Vanderbilt Awarded $16.5M to Determine how Toxic Agents Affect Human Cells|
Friday, March 07, 2014
As part of the Rapid Threat Assessment program, the team will seek to develop mass spec methods for quickly determining how potentially toxic agents affect human cells.
Proteomics International, inVentiv Health Sign Biosimilar Agreement
Saturday, March 01, 2014
Partnership offers developers full service biosimilar expertise on a global scale.
Empiriko, Interchim Sign Partnership Agreement
Thursday, February 27, 2014
Empiriko will leverage Interchim's PuriFlash®/MassSpec technology to conduct in vitro and ex-vivo drug metabolism studies using its Biomimiks™ technology.
Agilent's LC/MS Purification System a Winner in Analytical Scientist Innovation Awards
Saturday, February 22, 2014
Magazine names 1260 Infinity series one of top 15 game-changing technologies of 2013.
Ezose Sciences Receives Grant from Michael J. Fox Foundation
Thursday, February 20, 2014
Foundation to apply Ezose’s Glycan Map technology to investigating the role of glycans in Parkinson’s disease.
Bruker Reports 7% Revenue Growth in Q4
Wednesday, February 19, 2014
Bruker Corporation reported financial results for its fourth quarter and full year ended December 31, 2013.
The Role of Mass Spectrometry in the "Omics" Era
Tuesday, February 18, 2014
The tremendous developments of the MS technology and concurrent gene sequencing efforts have made the “-omic” revolution possible.
Shimadzu Opens New Solution Center at North American HQ
Saturday, February 08, 2014
New, innovative, 4,100-square-foot facility now open to customers.
Avacta Collaborate with University of Liverpool
Tuesday, February 04, 2014
Collaboration aims to deliver powerful new methods for biomarker and drug target discovery.